|
1
|
Glavinas H, Krajcsi P, Cserepes J and
Sarkadi B: The role of ABC transporters in drug resistance,
metabolism and toxicity. Curr Drug Deliv. 1:27–42. 2004. View Article : Google Scholar
|
|
2
|
Varma MV, Ashokraj Y, Dey CS and
Panchagnula R: P-glycoprotein inhibitors and their screening: A
perspective from bioavailability enhancement. Pharmacol Res.
48:347–359. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Marie JP, Zittoun R and Sikic BI:
Multidrug resistance (mdr1) gene expression in adult acute
leukemias: Correlations with treatment outcome and in vitro drug
sensitivity. Blood. 78:586–592. 1991.PubMed/NCBI
|
|
4
|
Huang Z, Zhang S, Shen Y, Liu W, Long J
and Zhou S: Influence of MDR1 methylation on the curative effect of
interventional embolism chemotherapy for cervical cancer. Ther Clin
Risk Manag. 12:217–223. 2016.PubMed/NCBI
|
|
5
|
Polyak K, Lee MH, Erdjument-Bromage H,
Koff A, Roberts JM, Tempst P and Massagué J: Cloning of
p27Kip1, a cyclin-dependent kinase inhibitor and a
potential mediator of extracellular antimitogenic signals. Cell.
78:59–66. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhao Y, Li Q, Wu X and Chen P:
Upregulation of p27Kip1 by demethylation sensitizes
cisplatin-resistant human ovarian cancer SKOV3 cells. Mol Med Rep.
14:1659–1666. 2016.PubMed/NCBI
|
|
7
|
Yang Y, Chen Y, Saha MN, Chen J, Evans K,
Qiu L, Reece D, Chen GA and Chang H: Targeting phospho-MARCKS
overcomes drug-resistance and induces antitumor activity in
preclinical models of multiple myeloma. Leukemia. 29:715–726. 2015.
View Article : Google Scholar
|
|
8
|
Sun L, Liu L, Liu X, Wang Y, Li M, Yao L,
Yang J, Ji G, Guo C, Pan Y, et al: Gastric cancer cell adhesion to
laminin enhances acquired chemotherapeutic drug resistance mediated
by MGr1-Ag/37LRP. Oncol Rep. 32:105–114. 2014.PubMed/NCBI
|
|
9
|
Fei M, Hang Q, Hou S and Ruan C: Cell
adhesion to fibronectin down-regulates the expression of Spy1 and
contributes to drug resistance in multiple myeloma cells. Int J
Hematol. 98:446–455. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Carrano AC, Eytan E, Hershko A and Pagano
M: SKP2 is required for ubiquitin-mediated degradation of the CDK
inhibitor p27. Nat Cell Biol. 1:193–199. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Masumoto K and Kitagawa M: E3 ubiquitin
ligases as molecular targets in human oral cancers. Curr Cancer
Drug Targets. 16:130–135. 2016. View Article : Google Scholar
|
|
12
|
Yan LH, Wang XT, Yang J, Kong FB, Lian C,
Wei WY, Luo W, Xie YB and Xiao Q: Reversal of multidrug resistance
in gastric cancer cells by E2F-1 downregulation in vitro and in
vivo. J Cell Biochem. 115:34–41. 2014. View Article : Google Scholar
|
|
13
|
Hnit SS, Xie C, Yao M, Holst J, Bensoussan
A, De Souza P, Li Z and Dong Q: p27(Kip1) signaling:
Transcriptional and post-translational regulation. Int J Biochem
Cell Biol. 68:9–14. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Friis-Hansen L, Sundler F, Li Y, Gillespie
PJ, Saunders TL, Greenson JK, Owyang C, Rehfeld JF and Samuelson
LC: Impaired gastric acid secretion in gastrin-deficient mice. Am J
Physiol. 274:G561–G568. 1998.PubMed/NCBI
|
|
15
|
Rehfeld JF, Hansen CP and Johnsen AH:
Post-poly(Glu) cleavage and degradation modified by O-sulfated
tyrosine: A novel post-translational processing mechanism. EMBO J.
14:389–396. 1995.PubMed/NCBI
|
|
16
|
Goetze JP, Eiland S, Svendsen LB, Vainer
B, Hannibal J and Rehfeld JF: Characterization of gastrins and
their receptor in solid human gastric adenocarcinomas. Scand J
Gastroenterol. 48:688–695. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Merali Z, McIntosh J and Anisman H: Role
of bombesin-related peptides in the control of food intake.
Neuropeptides. 33:376–386. 1999. View Article : Google Scholar
|
|
18
|
Han YM, Park JM, Kangwan N, Jeong M, Lee
S, Cho JY, Ko WJ and Hahm KB: Role of proton pump inhibitors in
preventing hypergastrinemia-associated carcinogenesis and in
antagonizing the trophic effect of gastrin. J Physiol Pharmacol.
66:159–167. 2015.PubMed/NCBI
|
|
19
|
Lloyd KA, Moore AR, Parsons BN, O'Hara A,
Boyce M, Dockray GJ, Varro A and Pritchard DM: Gastrin-induced
miR-222 promotes gastric tumor development by suppressing p27kip1.
Oncotarget. 7:45462–45478. 2016.PubMed/NCBI
|
|
20
|
Niu YL, Li YJ, Wang JB, Lu YY, Liu ZX,
Feng SS, Hu JG and Zhai HH: CacyBP/SIP nuclear translocation
regulates p27Kip1 stability in gastric cancer cells. World J
Gastroenterol. 22:3992–4001. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhuang K, Yan Y, Zhang X, Zhang J, Zhang L
and Han K: Gastrin promotes the metastasis of gastric carcinoma
through the β-catenin/TCF-4 pathway. Oncol Rep. 36:1369–1376.
2016.PubMed/NCBI
|
|
22
|
Varro A, Kenny S, Hemers E, McCaig C,
Przemeck S, Wang TC, Bodger K and Pritchard DM: Increased gastric
expression of MMP-7 in hypergastrinemia and significance for
epithelial-mesenchymal signaling. Am J Physiol Gastrointest Liver
Physiol. 292:G1133–G1140. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kumar JD, Steele I, Moore AR, Murugesan
SV, Rakonczay Z, Venglovecz V, Pritchard DM, Dimaline R, Tiszlavicz
L, Varro A, et al: Gastrin stimulates MMP-1 expression in gastric
epithelial cells: Putative role in gastric epithelial cell
migration. Am J Physiol Gastrointest Liver Physiol. 309:G78–G86.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Singh P, Owlia A, Varro A, Dai B,
Rajaraman S and Wood T: Gastrin gene expression is required for the
proliferation and tumorigenicity of human colon cancer cells.
Cancer Res. 56:4111–4115. 1996.PubMed/NCBI
|
|
25
|
Hayashi N, Kayo T, Sugano K and Takeuchi
T: Production of bioactive gastrin from the non-endocrine cell
lines CHO and COS-7. FEBS Lett. 337:27–32. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Supriatno HK, Harada K, Hoque MO, Bando T,
Yoshida H and Sato M: Overexpression of p27(Kip1) induces growth
arrest and apoptosis in an oral cancer cell line. Oral Oncol.
38:730–736. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yin Y, Grabowska AM, Clarke PA, Whelband
E, Robinson K, Argent RH, Tobias A, Kumari R, Atherton JC and
Watson SA: Helicobacter pylori potentiates epithelial:mesenchymal
transition in gastric cancer: Links to soluble HB-EGF, gastrin and
matrix metalloproteinase-7. Gut. 59:1037–1045. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sumimoto H, Yamagata S, Shimizu A, Miyoshi
H, Mizuguchi H, Hayakawa T, Miyagishi M, Taira K and Kawakami Y:
Gene therapy for human small-cell lung carcinoma by inactivation of
Skp-2 with virally mediated RNA interference. Gene Ther. 12:95–100.
2005. View Article : Google Scholar
|
|
29
|
Hristova NR, Tagscherer KE, Fassl A,
Kopitz J and Roth W: Notch1-dependent regulation of p27 determines
cell fate in colorectal cancer. Int J Oncol. 43:1967–1975.
2013.PubMed/NCBI
|
|
30
|
Del Vecchio CA, Feng Y, Sokol ES, Tillman
EJ, Sanduja S, Reinhardt F and Gupta PB: De-differentiation confers
multidrug resistance via noncanonical PERK-Nrf2 signaling. PLoS
Biol. 12:e10019452014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Conway RM, Madigan MC, Billson FA and
Penfold PL: Vincristine- and cisplatin-induced apoptosis in human
retinoblastoma. Potentiation by sodium butyrate. Eur J Cancer.
34:1741–1748. 1998. View Article : Google Scholar
|
|
32
|
Gutkind JS: The pathways connecting G
protein-coupled receptors to the nucleus through divergent
mitogen-activated protein kinase cascades. J Biol Chem.
273:1839–1842. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Stendahl M, Nilsson S, Wigerup C, Jirström
K, Jönsson PE, Stål O and Landberg G: p27Kip1 is a
predictive factor for tamoxifen treatment response but not a
prognostic marker in premenopausal breast cancer patients. Int J
Cancer. 127:2851–2858. 2010. View Article : Google Scholar
|
|
34
|
Tsvetkov LM, Yeh KH, Lee SJ, Sun H and
Zhang H: p27(Kip1) ubiquitination and degradation is regulated by
the SCF(Skp2) complex through phosphorylated Thr187 in p27. Curr
Biol. 9:661–664. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Marshall KM, Laval M, Estacio O, Hudson
DF, Kalitsis P, Shulkes A, Baldwin GS and Patel O: Activation by
zinc of the human gastrin gene promoter in colon cancer cells in
vitro and in vivo. Metallomics. 7:1390–1398. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Reed JC, Miyashita T, Takayama S, Wang HG,
Sato T, Krajewski S, Aimé-Sempé C, Bodrug S, Kitada S and Hanada M:
BCL-2 family proteins: Regulators of cell death involved in the
pathogenesis of cancer and resistance to therapy. J Cell Biochem.
60:23–32. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Mao JD, Wu P, Xia XH, Hu JQ, Huang WB and
Xu GQ: Correlation between expression of gastrin, somatostatin and
cell apoptosis regulation gene bcl-2/bax in large intestine
carcinoma. World J Gastroenterol. 11:721–725. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Gandhi L, Camidge DR, Ribeiro de Oliveira
M, Bonomi P, Gandara D, Khaira D, Hann CL, McKeegan EM, Litvinovich
E, Hemken PM, et al: Phase I study of Navitoclax (ABT-263), a novel
Bcl-2 family inhibitor, in patients with small-cell lung cancer and
other solid tumors. J Clin Oncol. 29:909–916. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
De Milito A and Fais S: Proton pump
inhibitors may reduce tumour resistance. Expert Opin Pharmacother.
6:1049–1054. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Rintoul RC and Sethi T: Extracellular
matrix regulation of drug resistance in small-cell lung cancer.
Clin Sci (Lond). 102:417–424. 2002. View Article : Google Scholar
|
|
41
|
Hara T, Kamura T, Kotoshiba S, Takahashi
H, Fujiwara K, Onoyama I, Shirakawa M, Mizushima N and Nakayama KI:
Role of the UBL-UBA protein KPC2 in degradation of p27 at G1 phase
of the cell cycle. Mol Cell Biol. 25:9292–9303. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Nakayama K, Nagahama H, Minamishima YA,
Matsumoto M, Nakamichi I, Kitagawa K, Shirane M, Tsunematsu R,
Tsukiyama T, Ishida N, et al: Targeted disruption of Skp2 results
in accumulation of cyclin E and p27(Kip1), polyploidy and
centrosome overduplication. EMBO J. 19:2069–2081. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Nakayama K, Nagahama H, Minamishima YA,
Miyake S, Ishida N, Hatakeyama S, Kitagawa M, Iemura S, Natsume T
and Nakayama KI: Skp2-mediated degradation of p27 regulates
progression into mitosis. Dev Cell. 6:661–672. 2004. View Article : Google Scholar : PubMed/NCBI
|
